Literature DB >> 16082305

Value of contrast-enhanced magnetic resonance cholangiography in patients undergoing laparoscopic cholecystectomy.

Hakan Mutlu1, C Cinar Basekim, Emir Silit, Zekai Pekkafali, Cengiz Erenoglu, Mecit Kantarci, A Fevzi Karsli, Esref Kizilkaya.   

Abstract

Laparoscopic cholecystectomy (LC) is the preferred treatment of symptomatic gallstone disease. Biliary injury during LC is still a serious problem. Knowledge of anatomic detail is important for not encountering the injury. Magnetic resonance cholangiography (MRC) is a noninvasive method for imaging the biliary ducts. However, MRC has many drawbacks such as not showing anatomic structures in detail and respiratory motion. In this study, contrast-enhanced MRC is used to show cystic ducts that are not seen by MRC. Reasons for patient referral for MRC and contrast-enhanced MRC included suspicion of cholecystolithiasis, adenomyomatosis, and gallbladder polyp. Our results show that routine MRC revealed cystic ducts in 38 patients (77.5%) and contrast-enhanced MRC in 46 patients (93.8%). Intraoperative cholangiography (IOC) was taken as gold standard for all patients. We found that contrast-enhanced MRC can provide a useful supplement to MRC in patients with nonvisualized cystic ducts by MRC. To our knowledge, this is the first study of visualization of cystic duct in patients undergoing LC depicted by both MRC and contrast-enhanced MRC.

Entities:  

Mesh:

Year:  2005        PMID: 16082305     DOI: 10.1097/01.sle.0000174553.17543.fa

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  1 in total

1.  Preoperative evaluation of the cystic duct for laparoscopic cholecystectomy: comparison of navigator-gated prospective acquisition correction- and conventional respiratory-triggered techniques at free-breathing 3D MR cholangiopancreatography.

Authors:  Ryo Itatani; Tomohiro Namimoto; Hiroo Kajihara; Akira Yoshimura; Kazuhiro Katahira; Jiro Nasu; Ikuo Matsushita; Fumi Sakamoto; Masafumi Kidoh; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2013-02-27       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.